Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2025 Results on January 28, 2026

Elevance Health (NYSE: ELV) is set to announce its financial results for the fourth quarter and full year of 2025 on January 28, 2026. The release is scheduled for 6:00 a.m. Eastern Standard Time (EST), followed by a management conference call at 8:30 a.m. EST to discuss the findings and provide guidance for future performance. Interested participants are encouraged to join the call at least 15 minutes in advance using designated access numbers: 888-947-9963 (domestic) or 312-470-0178 (international), both requiring the access code 3972058.

For those unable to attend live, a replay of the call will be available later in the day, with domestic replays accessible at 888-566-0046 and international replays at 203-369-3677. The replay will remain open until February 27, 2026. Additionally, the call will be broadcasted via a live webcast, which can be accessed through the Elevance Health website under the “Investors” tab.

Elevance Health, a dedicated health partner, focuses on improving healthcare access for consumers, families, and communities throughout the healthcare journey. With a mission to enhance the health of humanity, Elevance Health provides an extensive range of services, including medical, pharmacy, behavioral, and complex care solutions, serving approximately 109 million consumers.

For more in-depth information, investors and interested parties can visit the official website at www.elevancehealth.com or engage with their social media through X and LinkedIn. For inquiries, Nathan Rich from Investor Relations and Leslie Porras from Media Relations are available via the provided email addresses. This conference call represents a vital opportunity for stakeholders to gain insights into Elevance Health's performance and future direction.

As Elevance Health (NYSE: ELV) prepares to release its fourth quarter and full year 2025 financial results on January 28, 2026, investors should approach this milestone with a strategy of informed caution. The anticipated revenue and performance metrics will offer visibility into the company's growth trajectory amidst a turbulent healthcare landscape.

With the company's commitment to being a lifetime health partner, Elevance's diverse service portfolio—encompassing medical, pharmacy, behavioral health, and clinical solutions—positions it well to capitalize on expanding market demands. Investors should watch for commentary on member growth and retention rates, as these metrics are crucial in assessing the company’s competitive positioning.

It's also prudent to monitor how management addresses potential challenges, particularly those arising from regulatory changes and economic pressures that may affect healthcare spending. The upcoming conference call, scheduled for 8:30 a.m. EST on the same day, will serve as a key opportunity for executives to provide insights into strategies for navigating these hurdles.

The significance of this call cannot be overstated. A well-received report could bolster investor confidence and potentially lead to positive price action. Conversely, any negative surprises—such as lower-than-expected earnings or unfavorable guidance—could pose risks for short-term stock performance.

Given the current market environment, it may be advisable to adopt a "Hold" position until the results and management's outlook are fully disclosed. This approach allows for prudent reassessment based on Elevance's fourth-quarter performance and the outlook provided during the call. In summary, pay close attention to the call, as it will significantly inform investment decisions regarding Elevance Health in the immediate future.